Gilazieva Z., Moldavskii D., Luzina E., Kadyrova A., Shaimardanova A., Issa S., Rizvanov A., Solovyeva V. 2024. Extracellular vesicles as brain tumor biomarkers. Biocell. 48 (12), 1667–1681.

Article  CAS  Google Scholar 

Shah V., Kochar P. 2018. Brain cancer: Implication to disease, therapeutic strategies and tumor targeted drug delivery approaches. Recent Pat. Anti-Cancer Drug Discovery. 13 (1), 70–85.

Article  CAS  PubMed  Google Scholar 

Capper D., Jones D.T.W., Sill M., Hovestadt V., Schrimpf D., Sturm D., Koelsche C., Sahm F., Chavez L., Reuss D.E., Kratz A., Wefers A.K., Huang K., Pajtler K.W., Schweizer L., Stichel D., Olar A., Engel N.W., Lindenberg K., Harter P.N., Braczynski A.K., Plate K.H., Dohmen H., Garvalov B.K., Coras R., Holsken A., Hewer E., Bewerunge-Hudler M., Schick M., Fischer R., Beschorner R., Schittenhelm J., Staszewski O., Wani K., Varlet P., Pages M., Temming P., Lohmann D., Selt F., Witt H., Milde T., Witt O., Aronica E., Giangaspero F., Rushing E., Scheurlen W., Geisenberger C., Rodriguez F.J., Becker A., Preusser M., Haberler C., Bjerkvig R., Cryan J., Farrell M., Deckert M., Hench J., Frank S., Serrano J., Kannan K., Tsirigos A., Bruck W., Hofer S., Brehmer S., Seiz-Rosenhagen M., Hanggi D., Hans V., Rozsnoki S., Hansford J.R., Kohlhof P., Kristensen B.W., Lechner M., Lopes B., Mawrin C., Ketter R., Kulozik A., Khatib Z., Heppner F., Koch A., Jouvet A., Keohane C., Muhleisen H., Mueller W., Pohl U., Prinz M., Benner A., Zapatka M., Gottardo N.G., Driever P.H., Kramm C.M., Muller H.L., Rutkowski S., von Hoff K., Fruhwald M.C., Gnekow A., Fleischhack G., Tippelt S., Calaminus G., Monoranu C.M., Perry A., Jones C., Jacques T.S., Radlwimmer B., Gessi M., Pietsch T., Schramm J., Schackert G., Westphal M., Reifenberger G., Wesseling P., Weller M., Collins V.P., Blumcke I., Bendszus M., Debus J., Huang A., Jabado N., Northcott P.A., Paulus W., Gajjar A., Robinson G.W., Taylor M.D., Jaunmuktane Z., Ryzhova M., Platten M., Unterberg A., Wick W., Karajannis M.A., Mittelbronn M., Acker T., Hartmann C., Aldape K., Schuller U., Buslei R., Lichter P., Kool M., Herold-Mende C., Ellison D.W., Hasselblatt M., Snuderl M., Brandner S., Korshunov A., von Deimling A. Pfister S.M. 2018. DNA methylation-based classification of central nervous system tumours. Nature. 555 (7697), 469–474.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louis D.N., Perry A., Wesseling P., Brat D.J., Cree I.A., Figarella-Branger D., Hawkins C., Ng H.K., Pfister S.M., Reifenberger G., Soffietti R., von Deimling A., Ellison D.W. 2021. The 2021 WHO Classification of Tumors of the Central Nervous System: A summary. Neuro Oncol. 23 (8), 1231–1251.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tandel S.G., Biswas M., Kakde G.O., Tiwari A., Suri S.H., Turk M., Laird J.R., Asare C.K., Ankrah A.A., Khanna N.N., Madhusudhan K.B., Saba L., Suri J.S. 2019. A review on a deep learning perspective in brain cancer classification. Cancers (Basel). 11 (1), 111.

Article  Google Scholar 

Kaprin A.D., Starinsky V.V., Shahzadova A.O. 2024. Malignant Neoplasms in Russia in 2023 (Morbidity and Mortality). Moscow: Hertsen MORI—branch of the NMRRC of the Ministry of Health of the Russian Federation, 2767.

Neganova M.E., Aleksandrova Y.R., Sukocheva O.A., Klochkov S.G. 2022. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin. Cancer Biol. 86 (Pt 2), 805–833.

Article  CAS  PubMed  Google Scholar 

Zhou Y., Peng Z., Seven E.S., Leblanc R.M. 2018. Crossing the blood-brain barrier with nanoparticles. J. Controlled Release. 270, 290–303.

Article  CAS  Google Scholar 

Castresana J.S., Melendez B. 2023. Glioblastoma biology, genetics and possible therapies. Cells. 12 (16), 2063.

Article  PubMed  PubMed Central  Google Scholar 

Katta N., Estrada A.D., McElroy A.B., Gruslova A., Oglesby M., Cabe A.G., Feldman M.D., Fleming R.D., Brenner A.J., Milner T.E. 2019. Laser brain cancer surgery in a xenograft model guided by optical coherence tomography. Theranostics. 9 (12), 3555–3564.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verburg N., de Witt Hamer P.C. 2021. State-of-the-art imaging for glioma surgery. Neurosurg. Rev. 44 (3), 1331–1343.

Article  PubMed  Google Scholar 

Odia Y., Gutierrez A.N., Kotecha R. 2022. Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: a comprehensive review. Neuro Oncol. 24 (Suppl 6), S16–S24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blakeley J., Grossman S.A. 2012. Chemotherapy with cytotoxic and cytostatic agents in brain cancer. Handb. Clin. Neurol. 104, 229–254.

Article  PubMed  Google Scholar 

Lamas C., Camara R., Fajardo C., Remon-Ruiz P., Biagetti B., Guerrero-Perez F., Araujo-Castro M., Mora M., Hanzu F., Iglesias P., Garcia-Centeno R., Soto A. 2023. Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain. Front. Endocrinol. (Lausanne). 14, 1204206.

Article  Google Scholar 

Chuang D.F., Lin X. 2019. Targeted therapies for the treatment of glioblastoma in adults. Curr. Oncol. Rep. 21 (7), 61.

Article  PubMed  Google Scholar 

Cruz J.V.R., Batista C., Afonso B.H., Alexandre-Moreira M.S., Dubois L.G., Pontes B., Moura Neto V., Mendes F.A. 2022. Obstacles to glioblastoma treatment two decades after temozolomide. Cancers. 14 (13), 3203.

Chulpanova D.S., Kitaeva K.V., Rutland C.S., Rizvanov A.A., Solovyeva V.V. 2020. Mouse tumor models for advanced cancer immunotherapy. Int. J. Mol. Sci. 21 (11), 4118.

Kitaeva, K.V., Rutland C.S., Rizvanov A.A., Solovyeva V.V. 2020. Cell culture based in vitro test systems for anticancer drug screening. Front. Bioeng. Biotechnol. 8, 322.

Article  PubMed  PubMed Central  Google Scholar 

Amaral R.L.F., Miranda M., Marcato P.D., Swiech K. 2017. Comparative analysis of 3D bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening. Front. Physiol. 8, 605.

Article  PubMed  PubMed Central  Google Scholar 

Barbosa M.A.G., Xavier C.P.R., Pereira R.F., Petrikaite V., Vasconcelos M.H. 2021. 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs. Cancers. 14 (1), 190

Article  PubMed  PubMed Central  Google Scholar 

Neufeld L., Yeini E., Reisman N., Shtilerman Y., Ben-Shushan D., Pozzi S., Madi A., Tiram G., Eldar-Boock A., Ferber S., Grossman R., Ram Z., Satchi-Fainaro R. 2021. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Sci. Adv. 7 (34), 9119

Article  Google Scholar 

Stein G.H. 1979. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J. Cell Physiol. 99 (1), 43–54.

Article  CAS  PubMed  Google Scholar 

Candolfi M., Curtin J.F., Nichols W.S., Muhammad A.G., King G.D., Pluhar G.E., McNiel E.A., Ohlfest J.R., Freese A.B., Moore P.F., Lerner J., Lowenstein P.R., Castro M.G. 2007. Intracranial glioblastoma models in preclinical neuro-oncology: Neuropathological characterization and tumor progression. J. Neurooncol. 85 (2), 133–148.

Article  PubMed  PubMed Central  Google Scholar 

Liu P., Griffiths S., Veljanoski D., Vaughn-Beaucaire P., Speirs V., Bruning-Richardson A. 2021. Preclinical models of glioblastoma: Limitations of current models and the promise of new developments. Expert Rev. Mol. Med. 23, e20.

Article  CAS  PubMed  Google Scholar 

Suvà M.L., Tirosh I. 2020. The glioma stem cell model in the era of single-cell genomics. Cancer Cell. 37 (5), 630–636.

Article  PubMed  Google Scholar 

Hersh A.M., Gaitsch H., Alomari S., Lubelski D., Tyler B.M. 2022. Molecular pathways and genomic landscape of glioblastoma stem cells: Opportunities for targeted therapy. Cancers. 14 (15), 3743.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gimple R.C., Bhargava S., Dixit D., Rich J.N. 2019. Glioblastoma stem cells: Lessons from the tumor hierarchy in a lethal cancer. Genes. Dev. 33 (11–12), 591–609.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. 2004. Identification of human brain tumour initiating cells. Nature. 432 (7015), 396–401.

Article  CAS  PubMed  Google Scholar 

Wang Z., Zhang H., Xu S., Liu Z., Cheng Q. 2021. The adaptive transition of glioblastoma stem cells and its implications on treatments. Signal Transduction Targeted. Ther. 6 (1), 124.

Article  CAS  Google Scholar 

Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. 2006. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444 (7120), 756–760.

Article  CAS  PubMed  Google Scholar 

Ahmed N., Salsman V.S., Kew Y., Shaffer D., Powell S., Zhang Y.J., Grossman R.G., Heslop H.E., Gottschalk S. 2010. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Clin. Cancer Res. 16 (2), 474–485.

Article  CAS  PubMed  PubMed Central